Category Archives: Vaccine Hesitancy Rate

Entering a new phase of the vaccine rollout

Posted on by • Posted in Coronavirus, Coronavirus Mutation, Herd Immunity, Infection Control, Infection Control Plan, Infectious Virus, National Strategy, Pandemic, Public Health, Scientists, Vaccine, Vaccine Development, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism, Vaccine Supply • Leave a comment

https://mailchi.mp/da8db2c9bc41/the-weekly-gist-april-23-2021?e=d1e747d2d8

Why some Americans are hesitant to receive the COVID-19 vaccine - Vital Record

With more than 222M Americans having received at least one dose of COVID vaccine, and 27.5 percent of the population now fully vaccinated, we are now nearing a point at which vaccine supply will exceed demand, signaling a new phase of the rollout.

This week, for the first time since February, the daily rate of vaccinations slowed substantially, down about 11 percent from last week on a seven-day rolling average. Several states and counties are dialing back requests for new vaccine shipments, and the New York Times reported that some local health departments are beginning to shutter mass vaccination sites as appointment slots go unfilled.

On Friday, the White House’s COVID response coordinator, Jeff Zients, said that the Biden administration now expects “daily vaccination rates will fluctuate and moderate,” after several weeks of accelerating pace. In every state, everyone over the age of 16 is now eligible to be vaccinated, but experts expect that demand from the “vaccine-eager” population will run out over the next two weeks, necessitating a more aggressive campaign to distribute vaccines in hard-to-reach populations, and to convince vaccine skeptics to get the shot.

Vaccine hesitancy, like so many other issues related to the COVID pandemic, has now become starkly politicized—one recent survey found that 43 percent of Republicans “likely will never get” the vaccine, as opposed to only 5 percent of Democrats. Another 12 percent of those surveyed, regardless of party identification, say they plan to “see how it goes” before getting the vaccine, a subset that will surely be unnerved by continued doubts about the safety of the Johnson & Johnson (J&J) vaccine.

An expert advisory panel on Friday recommended that use of the J&J shot be resumed, but advised that a warning be included about potential risk of rare blood clots in women under 50. The first three months of the COVID vaccination campaign have been a staggering success—but getting from 27 percent fully vaccinated to the 80 percent needed for “herd immunity” will likely be a much tougher slog.

U.S. lifts pause on Johnson & Johnson’s coronavirus vaccine

Posted on by • Posted in Coronavirus, Coronavirus Mutation, Food and Drug Administration (FDA), Infection Control, Infection Control Plan, Infectious Virus, Pandemic, Scientists, Vaccine, Vaccine Development, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism • Leave a comment
https://www.axios.com/johnson-johnson-vaccine-resume-fda-70b69ac5-14d2-404a-8cee-fe8693728f39.html?stream=health-care&utm_source=alert&utm_medium=email&utm_campaign=alerts_healthcare

The CDC and FDA on Friday lifted the recommended pause on use of Johnson & Johnson’s coronavirus vaccine, saying the benefits of the shot outweigh the risk of a rare blood clot disorder.

Why it matters: The move clears the way for states to immediately resume administering the one-shot vaccine.

  • The Johnson & Johnson shot had been seen as an important tool to fill gaps in the U.S. vaccination effort. But between the pause in its use and repeated manufacturing problems, its role in that effort is shrinking.

Driving the news: J&J shots have been paused for about two weeks, in response to reports that they may have caused serious blood clots in a small number of patients.

  • Only six people had experienced those blood clots at the time of the pause. The CDC said Friday that there have been nine additional cases.
  • Regulators said the number is small enough to safely resume the use of J&J’s vaccine.

What they’re saying: “Safety is our top priority. This pause was an example of our extensive safety monitoring working as they were designed to work — identifying even these small number of cases,” said acting FDA Commissioner Janet Woodcock.

  • “We’ve lifted the pause based on the FDA and CDC’s review of all available data and in consultation with medical experts and based on recommendations from the CDC’s Advisory Committee on Immunization Practices,” she said.
  • “We are confident that this vaccine continues to meet our standards for safety, effectiveness and quality.”

What’s next: Regulators said health care providers administering the shot and vaccine recipients should review revised fact sheets about the J&J vaccine, which includes information about the rare blood clot disorder.

  • That heightened attention is important because the standard treatment for blood clots can make this particular type of clot worse.

Yes, but: J&J was already a relatively small part of the overall domestic vaccination effort, in part because the company missed some of its early manufacturing targets.

  • Multiple problems have since emerged at a Baltimore facility that makes a key ingredient for the vaccine, which could sideline production for weeks.

Blood Clots, FDA Approval, and the AstraZeneca Covid Vaccine

Posted on by • Posted in Centers for Disease Control & Prevention (CDC), Clinical Research, Clinical Testing, Clinical Trials, Coronavirus, Coronavirus Mutation, Food and Drug Administration (FDA), Infection Control, Infection Control Plan, Infectious Virus, Pandemic, Scientists, Vaccine, Vaccine Development, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety • Leave a comment
Blood Clots, FDA Approval, and the AstraZeneca Covid Vaccine
Blood Clots, FDA Approval, and the AstraZeneca Covid Vaccine - YouTube

There’s a lot of anxiety about the AstraZeneca vaccine thanks to recent reports of incomplete data, as well as reports on blood clot risks. Let’s take a look at both issues in context, understanding the efficacy data before and after numbers were updated, and understanding blood clot risk in relation to other common situations where blood clots are a potential concern.

Could Dollar General help dramatically expand vaccine access?

Posted on by • Posted in Access & Quality of Healthcare, Centers for Disease Control & Prevention (CDC), Health Equity, Health Inequity, Health Policy, Infection Control, Infection Control Plan, Infectious Virus, Public Health, Retail Clinic, Retail Healthcare, Retail Pharmacy, Rural Health, Social Determinants of Health, Vaccination, Vaccine, Vaccine Distribution, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism, Vaccine Supply, Vulnerable Populations • Leave a comment

https://mailchi.mp/94c7c9eca73b/the-weekly-gist-april-16-2021?e=d1e747d2d8

CDC in Talks With Dollar General to Expand Vaccinations

For some time, we’ve been focused on the efforts of Walmart to launch and grow a care delivery business, especially as it has piloted an expanded primary care clinic offering in a handful of states. We’ve long thought that access to basic care at the scale that Walmart brings could be transformative, given that more than half of Americans visit a Walmart store every week. Along those same lines, we’ve always wondered why Dollar General and Dollar Tree—each with around four times as many retail locations as Walmart—haven’t gotten into the retail clinic or pharmacy businesses.

(Part of the answer is ultra-lean staffing—this piece gives a good sense of the basic, and troubling, economics of dollar stores.) Now, as the federal government ramps up its efforts to widely distribute the COVID vaccines, it turns out that the CDC is actively discussing a partnership with Dollar General to administer the shots.

A fascinating new paper (still in preprint) from researchers at Yale shows why this could be a true gamechanger. The Biden administration, through its partnership with national and independent pharmacy providers, aims to have a vaccination site within five miles of 90 percent of the US population by next week. Compared to those pharmacy partners, researchers found, Dollar General stores are disproportionately located in areas of high “social vulnerability”, with lower income residents and high concentrations of disadvantaged groups. Particularly in the Southeast, a partnership with Dollar General would vastly increase access for low-income Black and Latino residents, allowing vaccine access within one mile for many, many more people. And the partnership could form the basis for future expansions of basic healthcare services to vulnerable and rural communities, particularly if some of the $7.5B in funding for COVID vaccine distribution went to helping dollar store locations bolster staffing and equipment to deliver basic health services. We’ll be watching with interest to see if the potential Dollar General partnership comes to fruition.

Cartoon – No Vaccine for Stupidity

Posted on by • Posted in Cartoon, Disinformation, Misinformation, Public Health, Public Opinion, Public Perception, Public Safety, Public Trust, Scientists, Sign of the Times, Stupidity, Vaccination, Vaccine, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism • Leave a comment
Facebook Cracks Down on UK and Romanian Fake Accounts, Anti-Vaccine Posts | National News | US News

Cartoon – One Vaccine Prevents Disease & Another Conspiracy Theories

Posted on by • Posted in Cartoon, Conspiracy Theories, Denial, Disinformation, Evidence-Based Care, Facts, Misinformation, Public Health, Public Opinion, Public Perception, Public Trust, Scientists, Sign of the Times, Vaccine, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine History, Vaccine Safety, Vaccine Skepticism • Leave a comment
Hands on Wisconsin: Facts are the vaccine for conspiracies | Opinion | Cartoon | madison.com

Cartoon – Anti Vaxx Message is Spreading

Posted on by • Posted in Cartoon, Denial, Disinformation, Messaging, Misinformation, Preventable Disease, Public Health, Public Opinion, Public Perception, Public Trust, Scientists, Sign of the Times, Vaccination, Vaccine, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism • Leave a comment
Political Cartoon on Twitter: "Graeme Keyes on Doctors worried as anti- vaccination messages escalate from social media misinformation to personal threats - political cartoon gallery in London https://t.co/dePcTdnXF6… https://t.co/UH1eOU4nPh"

Cartoon – Vaccination from Making Decisions based on Politics

Posted on by • Posted in Cartoon, Decision Making, Denial, Disinformation, Misinformation, Partisanship, Politics, Public Health, Public Opinion, Public Perception, Scientists, Sign of the Times, Vaccination, Vaccine, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism • Leave a comment
Marshall Ramsey: Vaccination | Mississippi Today

Cartoon – A Shot of Common Sense

Posted on by • Posted in Common Sense, Denial, Disinformation, Misinformation, Public Health, Public Opinion, Public Perception, Public Trust, Sign of the Times, State of the Union, Vaccination, Vaccine, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism • Leave a comment
Vaccines must NOT be Feared” – STEM: From Roots to Fruits

Cartoon – The Mumps vs Chumps

Posted on by • Posted in Cartoon, Denial, Disinformation, Misinformation, Public Health, Public Opinion, Public Perception, Vaccination, Vaccine, Vaccine Distribution, Vaccine Efficacy, Vaccine Hesitancy Rate, Vaccine Safety, Vaccine Skepticism • Leave a comment
chumps